Clinical trials
Glucose Intolerance trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Unknown status | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Roehampton | 3 |
| Liverpool John Moores University | 2 |
| Oxford Brookes University | 2 |
| University of Leicester | 2 |
| University of Liverpool | 2 |
| Aberystwyth University | 1 |
| Anne Birgitte Raben | 1 |
| Atlantia Food Clinical Trials | 1 |
| Belfast Health and Social Care Trust | 1 |
| Chelsea and Westminster NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Intolerance | 38 |
| Diabetes Mellitus, Type 2 | 12 |
| Obesity | 5 |
| Diabetes Mellitus | 4 |
| Insulin Resistance | 4 |
| Glucose Metabolism Disorders | 3 |
| Hyperglycemia | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Prediabetic State | 3 |
| Fatty Liver | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.